SBSN drives bladder cancer metastasis via EGFR/SRC/STAT3 signalling Read for free using #SharedIt: rdcu.be/cMDMV #Bladdercancer #Oncogenes

Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade Read for free: go.nature.com/38M638r #Cancerstemcells #Metastasis

HIF-1α stimulates the progression of oesophageal squamous cell carcinoma by activating the Wnt/β-catenin signalling pathway Read for free using #SharedIt: rdcu.be/cMDNw #Cancermicroenvironment #Oncogenes

POH1/Rpn11/PSMD14: a journey from basic research in fission yeast to a prognostic marker and a druggable target in cancer cells Read for free: go.nature.com/3w2U8uV #Drugdevelopment #Molecularmedicine #Oncogenes

TXN inhibitor impedes radioresistance of colorectal cancer cells with decreased ALDH1L2 expression via TXN/NF-κB signaling pathway #OpenAccess in BJC: nature.com/articles/s4141… @zhang_yaowei

Inhibition of PFKFB3 in HER2-positive gastric cancer improves sensitivity to trastuzumab by inducing tumour vessel normalisation Read for free: rdcu.be/cPRNn

👏Excellent review on Liquid biopsies to monitor and direct cancer treatment in colorectal cancer! British Journal of Cancer doi.org/10.1038/s41416… 👉Ongoing trials will define the impact of ctDNA for decision making in #CRC ESMO - Eur. Oncology OncoAlert

The British Journal of Cancer is seeking an exceptional candidate to serve as Editor-in-Chief of the journal, starting January 1st 2023. For further information on the role please visit: nature.com/bjc/journal-in…. Application deadline: September 2nd 2022.

Edinburgh Cancer Research scientists report clinical and histopathological characterisation of the largest pathologically confirmed cohort of ovarian carcinosarcoma patients to date. New insights into this rare form of #ovariancancer! Published in British Journal of Cancer. Lay summary: ed.ac.uk/cancer-centre/…

Our new paper is just out! Circulating miRNAs for ovarian cancer diagnosis & prognosis British Journal of Cancer nature.com/articles/s4141… #liquidbiopsy #microrna #CancerResearch

What's the value of negative data? A new systematic review of Patient Attrition in Molecular Tumour Boards from our digital Experimental Cancer Medicine Team (published in British Journal of Cancer) shows the value of including the data that's normally left out of papers Read it here: nature.com/articles/s4141…

Just published! #BritishJournalofCancer #Cancer #HNC #Survival #smoking British Journal of Cancer nature nature.com/articles/s4141… 2/2

Digital Imaging: open to receiving submissions assessing: ▪️ State-of-the-art in digital imaging technology and computational output; ▪️ Radiomics; ▪️Algorithms and approaches designed to predict therapeutic response and enable “personalized medicine” nature.com/collections/bb…

Explore the exciting contributions to our Liquid Biopsy series, or consider submitting your own to collection: nature.com/collections/ae…

We are delighted to announce that the British Journal of Cancer has launched a new, fully open access partner journal, BJC Reports (nature.com/bjcreports). For pre-submission enquiries and applications to the Editorial Board, please contact us at [email protected].

Application is now open for the BJC Reports Trainee Editorial Board. Applicants should be early career researchers (postdoctoral), or clinicians and other health professionals on an approved training scheme in a cancer-related discipline: nature.com/bjcreports/edi…

Save the date! We are hosting a webinar on Cancer Associated Fibroblasts 🗓️ Wednesday 7th Jun 2023 ⏲️ 16.00 PM (Europe/London) Join us and our speakers Neta Erez- ErezLab🎗️ Ruth Shouval Alexandre Calon and Fatima Mechta-Grigoriou by registering here: cassyni.com/events/QAskRKN… Cancer at Nature Portfolio #CancerResearch

Explore a new special issue in British Journal of Cancer on 'Advances in #ImmuneCheckpointInhibitors use in cancer treatment': nature.com/collections/bg… Read the Editorial article for the collection by Guest Editors Prof Joseph Ciccolini & Dr Gerard Milano: nature.com/articles/s4141…

📢1/8 A subset of ER+/HER2- #breastcancer may benefit from #immunotherapy, but which tumors are these?🤔 Our latest study just out on British Journal of Cancer Springer Nature sheds light on this highly relevant topic Read more:📌rdcu.be/dqys9 Giampaolo Bianchini Maurizio Callari